Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1

被引：75

作者：

Riddle, MC

Drucker, DJ

机构：

[1] Univ Toronto, Toronto Gen Hosp, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada

[2] Univ Toronto, Toronto Gen Hosp, Dept Med, Toronto, ON M5G 2C4, Canada

[3] Oregon Hlth & Sci Univ, Div Endocrinol Diabet & Clin Nutr, Sect Diabet, Portland, OR 97201 USA

来源：

DIABETES CARE | 2006年 / 29卷 / 02期

关键词：

D O I：

10.2337/diacare.29.02.06.dc05-1267

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：435 / 449

页数：15

共 188 条

[1] ROLE OF HEPATIC NERVES IN RESPONSE OF LIVER TO INTRAPORTAL GLUCOSE DELIVERY IN DOGS [J].

ADKINSMARSHALL, B ;

PAGLIASSOTTI, MJ ;

ASHER, JR ;

CONNOLLY, CC ;

NEAL, DW ;

WILLIAMS, PE ;

MYERS, SR ;

HENDRICK, GK ;

ADKINS, RB ;

CHERRINGTON, AD .

AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :E679-E686

[2] Autonomic regulation of islet hormone secretion -: Implications for health and disease [J].

Ahrén, B .

DIABETOLOGIA, 2000, 43 (04) :393-410

[3] Improved meal-related β-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year [J].

Ahrén, B ;

Pacini, G ;

Foley, JE ;

Schweizer, A .

DIABETES CARE, 2005, 28 (08) :1936-1940

[4] Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes [J].

Ahrén, B ;

Landin-Olsson, M ;

Jansson, PA ;

Svensson, M ;

Holmes, D ;

Schweizer, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2078-2084

[5] Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes [J].

Ahrén, B ;

Gomis, R ;

Standl, E ;

Mills, D ;

Schweizer, A .

DIABETES CARE, 2004, 27 (12) :2874-2880

[6] The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia [J].

Ahrén, B ;

Holst, JJ .

DIABETES, 2001, 50 (05) :1030-1038

[7]

American Association of Clinical Endocrinologists and American College of Endocrinology, 2002, ENDOCR PRACT S1, V8, P5

[8] Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus [J].

Anderson, JH ;

Brunelle, RL ;

Keohane, P ;

Koivisto, VA ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1249-1255

[9]

[Anonymous], 1999, Diabet Med, V16, P716

[10]

[Anonymous], 2005, DIABETES CARE, V28, pS4

← 1 2 3 4 5 6 7 8 9 10 →